Congratulations to Professor Ian C.K. WONG

Congratulations to Professor Ian C.K. WONG

Professor Ian C.K. WONG has been named a Highly Cited Researcher in 2024 by Clarivate Analytics. This accolade honors the world's leading researchers who have demonstrated significant influence through the publication of multiple papers that rank in the top 1% by citations over the past decade.

Details: HKU Press Release

Congratulations to our student Ms. Chan Hoi Ki

Congratulations to our student Ms. Chan Hoi Ki, Doris for winning the honor of being one of the Top Ten Outstanding Tertiary Students in Hong Kong at the awards ceremony held on October 26, 2024, by the Hong Kong Youth & Tertiary Students Association (HKYTSA).

Details:
https://www.facebook.com/share/mj9G6Fdt2opwi4Xc/

Interview with the winners:
https://bit.ly/3YQZFEG

Congratulations to Mr. Howard Chan

Mr. Howard Chan, PhD Student under the supervision of Professor Aviva S.F. CHOW, was awarded Career Development Award for 2024 from Drug Delivery to Lungs (DDL) Conference.

Congratulations to Mr. Yichi Zhang

Mr. Yichi Zhang, PhD Student under the supervision of Professor W.P. WANG, was awarded the HKU Research Postgraduate Student Innovation Award 2023/24.

Link: https://intraweb.hku.hk/reserved_1/gradsch/awardee_list/Inno-awardee_list_February-2024.pdf

Congratulations to Mr. Howard Chan

Mr. Howard Chan, PhD Student under the supervision of Professor Aviva S.F. CHOW, was awarded Sir Edward Youde Memorial Fellowships for Postgraduate Research Students 2023/24.

HKUMed develops groundbreaking monoclonal antibody for treating cerebral ischaemia injury

HKUMed develops groundbreaking monoclonal antibody for treating cerebral ischaemia injury

https://www.hku.hk/press/press-releases/detail/27103.html

HKUMed achieves breakthrough in photoactivatable nanomedicine for the treatment of age-related macular degeneration

HKUMed achieves breakthrough in photoactivatable nanomedicine for the treatment of age-related macular degeneration

https://www.med.hku.hk/en/news/press/20231123-HKUMed-achieves-breakthrough-in-photoactivatable-nanomedicine

HKUMed finds 52% and 66% death reduction for molnupiravir and nirmatrelvir-ritonavir users among inpatients with COVID-19; supports early use of oral antivirals in this population of patients

HKUMed finds 52% and 66% death reduction for molnupiravir and nirmatrelvir-ritonavir users among inpatients with COVID-19; supports early use of oral antivirals in this population of patients

https://www.med.hku.hk/en/news/press/20221003-molnupiravir-nirmatrelvir-ritonavi (English)

https://www.med.hku.hk/zh-hk/news/press/20221003-molnupiravir-nirmatrelvir-ritonavi (Chinese)

HKUMed finds risk of myocarditis in adolescents significantly reduced after receiving only one dose of Comirnaty; adolescents urged to get the first dose of COVID-19 vaccine

HKUMed finds risk of myocarditis in adolescents significantly reduced after receiving only one dose of Comirnaty; adolescents urged to get the first dose of COVID-19 vaccine

Click to view full text of Press Release

Media coverage:

The Standard Online

Date: January 25, 2022

Topic: Single BioNTech jab significantly reduces myocarditis risk for teens – HKU research

Link: https://bit.ly/3u7C3MS

RTHK Chinese Instant News

Date: January 25, 2022

Topic: 青少年延長至少三個月打第二針復必泰可降心肌炎機會

Link: https://bit.ly/3r2pG2D

RTHK Chinese Instant News

Date: January 25, 2022

Topic: 學者建議 12 歲或以上青少年盡快接種第一劑疫苗

Link: https://bit.ly/3G19dA5

CRHK Instant News

Date: January 25, 2022

Topic: 港大研究：青少年接種 2 劑復必泰後 患心肌炎風險較接種 1 劑高 6 倍

Link: https://bit.ly/3AOT4wV

Now TV News

Date: January 25, 2022

Topic: 港大：僅打一針復必泰可大幅降低青少年患心肌炎機會

Link: https://bit.ly/3G51r8j

Ming Pao Instant News

Date: January 25, 2022

Topic: 港大研究：12 歲以上青少年打兩針復必泰 患心肌炎風險為打一針 7 倍

Link: https://bit.ly/3KPezBY

on.cc Instant News

Date: January 25, 2022

Topic: 青少年接種復必泰後 3 周打第二針 患心肌炎風險增逾 7 倍

Link: https://bit.ly/3H502jj

HKEJ Instant News

Date: January 25, 2022

Topic: 港大:青少年打一針復必泰大幅減患心肌炎機會

Link: https://bit.ly/3G9KiKB

Wen Wei Po Instant News

Date: January 25, 2022

Topic: 【抗擊新冠肺炎】港大籲青少年首針後隔 3 個月再打

Link: https://bit.ly/3fXbMbY

am730 Instant News

Date: January 26, 2022

Topic: 青少年打復必泰二針 港大建議隔 3 個月

Link: https://bit.ly/3tXMXou

Sky Post Instant News

Date: January 25, 2022

Topic: 新冠疫苗｜兒童染疫失嗅覺險釀火警 專家指勿輕視後遺症 籲快打針

Link: https://bit.ly/3r3ztWk

Sky Post Instant News

Date: January 26, 2022

Topic: 青少年推遲次針復必泰 降心肌炎風險

Link: https://bit.ly/3IMol6p

HK01

Date: January 25, 2022

Topic: 復必泰｜港大：青少年打第一針 隔 3 個月打第二針可降心肌炎風險

Link: https://bit.ly/3u3SGZK

Topick.hket.com

Date: January 25, 2022

Topic: 【疫苗接種】港大研究發現青少年接種 2 劑復必泰患心肌炎風險較接種 1 劑高 6 倍 建議延長 3 個月後再打

Link: https://bit.ly/3IxxKhY

etnet

Date: January 25, 2022

Topic: 【新冠肺炎】研究：青少年接種１劑復必泰，患心肌炎風險較兩劑低

Link: https://bit.ly/3r1GtTF

Hkcna.hk

Date: January 25, 2022

Topic: 港大研究：僅打一針復必泰可降低青少年患心肌炎機會

Link: https://bit.ly/3HhSREw

Udn.com (Taiwan)

Date: January 26, 2022

Topic: 香港研究稱：青少年 2 劑 BNT 心肌炎風險較 1 劑高 6 倍

Link: https://bit.ly/3g12lZ1

Facing the dilemma between unmet needs and costly drugs: what are the strategic solutions for rare diseases?

Dr Shirley Li spoke as a panelist at the WHO webinar series on country pharmaceutical pricing policies and presented the “Global Access and Unmet Needs of Orphan Drugs” based on the team’s previous work published in Value in Health.

Click to view the full text of paper